Form 4: Abeona Therapeutics CFO Joseph Vazzano Reports Stock Disposal for Tax Obligations
SEC Form 4 Filing
Chief Financial Officer of Abeona Therapeutics, Joseph Vazzano, reports disposing of 685 shares of common stock to cover tax obligations upon vesting of restricted stock.
Summary
- Joseph Vazzano, the CFO of Abeona Therapeutics, filed a Form 4 detailing changes in beneficial ownership.
- On March 14, 2025, Vazzano disposed of 685 shares of common stock at a price of $5.29 per share.
- This disposal was to satisfy tax withholding obligations related to the vesting of restricted stock.
- Following the transaction, Vazzano directly owns 509,041 shares of Abeona Therapeutics common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing reflects a routine transaction for tax purposes and doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Disposals to cover tax obligations are common and don't necessarily indicate a negative outlook on the company.
Key Dates
| Date | Description |
|---|---|
| 03/14/2025 | Date of stock disposal transaction. |
| 03/17/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, Abeona Therapeutics, ABEO, Joseph Vazzano, CFO, Stock Disposal, Tax Obligations, Restricted Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.